Find a Test

The nature of possible underlying disease can be ruled out/confirmed through histopathological examination

Echinococcus granulosus infects dogs and other canines as the definitive host and sheep, cattle, goats, and humans as intermediate hosts. When eggs are liberated by an infected host and ingested by an intermediate host, they can hatch within the new host. Cystic hydatid disease often affects the liver but other organs may be involved. Antibodies testing detects echinococcoses.

Electrolyte panel is useful in assessing acid base balance in a wide variety of medical conditions.

Electrolyte panel is useful in assessing acid base balance in a wide variety of medical conditions.

The nature of possible underlying disease can be ruled out/confirmed through histopathological examination

The presence of endomysial antibodies IgG, may be useful in identifying IgA-deficient patients at risk for celiac disease. To establish the diagnosis of celiac disease, a positive result must be confirmed through a biopsy of the small intestine.

The nature of possible underlying disease can be ruled out/confirmed through histopathological examination

Entamoeba histolytica is a parasitic protozoan that can infect the digestive tract and occasionally other tissues. Antibodies IgG is useful in differentiating amoebiasis from other causes of liver cysts and parasitic infection.

Enteroviruses are positive-sense RNA viruses in the Picornaviridae family, which includes polioviruses (3 types). Detection of enterovirus nucleic acid by PCR is the most sensitive and also faster diagnostic method for the diagnosis of CNS infection caused by these viruses.

Air is actively drawn into the device via a vacuum source and the particles within the sampled air volume is captured on, or within the test media employed. The test media is incubated, colony forming units (CFU) recovered, counted and then the number of CFU per volume of air sampled is determined.

Varies with isolate. Useful for determining the source of a nosocomial infection.

Screening test to aid in diagnosis of asthma, bronchitis and some types of pneumonia.

Screening test to aid in diagnosis of asthma, bronchitis and some types of pneumonia.

The Epstein-Barr Virus (EBV) is the causative agent of infectious mononucleosis (IM). IM is an acute illness charecterized clinically by sore throat, fever and lymphadenopathy. The serodiagnosis of IM is established with a single acute phase serum by the detection of high levels of IgM and IgG Antibodies to VCA. VCAIgM antibodies usually disappear within 3-6 weeks after onset of illness.

Primary infection by EBV causes infectious mononucleosis, usually a self limiting disease in children and young adults. Infection with EBV can cause lymphoproliferative disorders including tumors. VCA IgM appears approximately 4-6 weeks after initial infection and declines after about 3 months.

The Epstein-Barr Virus (EBV) is the causative agent of infectious mononucleosis (IM). IM is an acute illness characterized clinically by sore throat, fever and lymphadenopathy. Previous EBV infections are identified by IgG Antibodies to VCA.

The Epstein-Barr Virus (EBV) is the causative agent of infectious mononucleosis (IM). IM is an acute illness characterized clinically by sore throat, fever and lymphadenopathy. In children,
5-10% of primary EBV infections are asymptomatic. By adulthood, 90 95% of most populations have demonstrable EBV antibodies.
EBV specific serodiagnostic tests are not usually needed in typical cases of IM, since 90% of the cases are heterophile-positive.
For heterophile-negative cases and for diagnosis in atypical cases, confirmation of infection by EBV-specific serology is
useful. The serodiagnosis of IM is established with a single acute phase serum by the detection of elevated levels of IgM and IgG antibodies to VCA. Antibodies conversion or decline in VCAIgM antibodies (they usually disappear within 3-6 weeks after onset) and the emergence of EBNA antibodies (they arise from 3 weeks to several months after onset) can confirm diagnosis.
Previous EBV infections are identified by IgG Antibodies to VCA and to EBNA.

The Epstein-Barr Virus (EBV) is the causative agent of infectious mononucleosis (IM). IM is an acute illness charecterized clinically by sore throat, fever and lymphadenopathy. Previous EBV infections are identified by IgG Antibodies to VCA.

The Epstein-Barr Virus (EBV) is the causative agent of infectious mononucleosis (IM). IM is an acute illness charecterized clinically by sore throat, fever and lymphadenopathy. This assay aids in serodiagnosis of EBV infection.

The Epstein-Barr Virus (EBV) is the causative agent of infectious mononucleosis (IM). IM is an acute illness charecterized clinically by sore throat, fever and lymphadenopathy. Previous EBV infections are identified by IgG Antibodies to VCA.

The Epstein-Barr Virus (EBV) is the causative agent of infectious mononucleosis (IM). IM is an acute illness characterized clinically by sore throat, fever and lymphadenopathy. The serodiagnosis of IM is established with a single acute
phase serum by the detection of high levels of IgM and IgG Antibodies to VCA. VCA-IgM an-
tibodies usually disappear within 3-6 weeks after onset of illness.

Infectious Mononucleosis is a viral disease caused by the Epstein-Barr virus (EBV) that affects the reticuloendothelial system and has a broad spectrum of clinical presentations. Monospot test, a form of the heterophile antibody test,is used for the rapid screening of infectious mononucleosis. The test may indicate that a person has a typical case of infectious mononucleosis, but does not confirm the presence of EBV infection. Results should be correlated with clinical and hematological findings.

Erythropoietin (EPO), is a large glycoprotein hormone secreted by the kidney which regulates RBC production. This assay is used as an aid in distinguishing primary from secondary polycythemia, differentiating appropriate secondary polycythemia (eg, high-altitude living, pulmonary disease, tobacco use) from inappropriate secondary polycythemia (eg, tumors), identifying candidates
for EPO replacement therapy (eg, chronic renal failure), and evaluating patients undergoing EPO replacement therapy who demonstrate an inadequate hematopoietic response.

The nature of possible underlying disease can be ruled out/confirmed through histopathological examination

The nature of possible underlying disease can be ruled out/confirmed through histopathological examination

Useful in differentiating inflammatory and neoplastic diseases and as an index of disease severity. CRP can be, additionally, used for monitoring inflammatory disease states.

This test is to be used for measuring the levels of estradiol in in vitro fertilization protocols and in women receiving hormone replacement therapy (HRT) via a patch. For patients receiving in vitro fertilization treatments, the assay can usually be performed with same day turn around time if sent to the laboratory within a specified time.

The placenta converts DHEA-S produced by the fetal adrenals to estriol and other estrogens. Estriol is useful in assessing the fetal adrenals and placenta during pregnancy. More commonly, estriol is one of the maternal serum biochemical markers used to screen for common chromosomal trisomies, especially Down syndrome.

The placenta converts DHEA-S produced by the fetal adrenals to estriol and other estrogens. Estriol is useful in assessing the fetal adrenals and placenta during pregnancy. More commonly, estriol is one of the maternal serum biochemical markers used to screen for common chromosomal trisomies, especially Down syndrome.

Estrone is primarily derived from metabolism of androstenedione in peripheral tissues, especially adipose tissues. Individuals
with obesity have increased conversion of androstenedione to estrone leading to higher concentrations. In addition, an increase in the ratio of estrone to estradiol may be useful in assessing menopause in women.

See individual assays

See individual assays

See individual assays

Everolimus is an immunosuppressive agent derived from sirolimus (rapamycin). Both drugs function via inhibition of mTOR signaling, and share similar pharmacokinetic and toxicity profiles.The blood drug concentration is commonly monitored during its use in organ transplant cases.

The nature of possible underlying disease can be ruled out/confirmed through histopathological examination

The nature of possible underlying disease can be ruled out/confirmed through histopathological examination

The nature of possible underlying disease can be ruled out/confirmed through histopathological examination